Opinion

Video

Overview of RSV Patient Populations

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Wanda Filer, MD, MBA

A panel of experts on respiratory syncytial virus (RSV) introduce themselves and give an overview of patients who are most affected by RSV.

Video content above is prompted by the following questions:

  • Which patient groups are most affected by RSV? Who would be a high-risk adult patient for RSV?
    • Do comorbidities, such as cardiovascular or respiratory diseases, predispose patients to more severe infections?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
5 experts in this video
5 experts in this video
Related Content
Clinician holding RSV vaccine | Image Credit: kitsawet - stock.adobe.com
May 14th 2025

Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use

Brooke McCormick
New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.
RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com
February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

Pearl Steinzor
High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.
Nursing home care | Image credit: Kzenon - stock.adobe.com
November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor
Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.
Air purifier | Image credit: Prathankarnpap - stock.adobe.com
November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia
Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.
RSV risk survey | Image credit: Richelle - stock.adobe.com
November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

Pearl Steinzor
New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.
Blood sample tube for RSV test. | Image credit: JUN LI - stock.adobe.com
November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia
Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo